Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00009633 · ClinicalTrials.gov registry record
Follow-up Visit of High Risk Infants
A clinical trial of Infant, Premature and Infant, Newborn, sponsored by NICHD Neonatal Research Network.
- Recruiting
- Registry status
- 68,000
- Enrollment target
- 20
- Study locations
NCT00009633: Recruiting study of Infant, Premature and Infant, Newborn, sponsored by NICHD Neonatal Research Network.
NCT00009633 is a study of Infant, Premature and Infant, Newborn that is actively recruiting participants, run by NICHD Neonatal Research Network. The registered enrollment target is 68,000 participants, above the 5,637-participant average among 16 other Infant, Premature trials with a reported enrollment target (1106% higher). The trial reports 20 study locations across 16 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00009633, a study of Infant, Premature and Infant, Newborn, is actively recruiting participants, sponsored by NICHD Neonatal Research Network.
- RECRUITING
- Registry status
- 68,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The NICHD Neonatal Research Network's Follow-Up study is a multi-center cohort in which surviving extremely low birth-weight infants born in participating network centers receive neurodevelopmental, neurosensory and functional assessments at 22-26 months corrected age (Infants born prior to July 1, 2012 were seen at 18-22 months corrected age). Data regarding pregnancy and neonatal outcome are collected prospectively. The goal is to identify potential maternal and neonatal risk factors that may affect infant neurodevelopment.
Conditions Studied
Interventions
- OTHER No Intervention
Study Locations (20)
California
- University of California - Los Angeles - Los Angeles
- Stanford University - Palo Alto
- University of California at San Diego - San Diego
- Sharp Mary Birch Hospital for Women & Newborns - San Diego
Massachusetts
- Tufts Medical Center - Boston
- Harvard University - Cambridge
Alabama
- University of Alabama at Birmingham - Birmingham
Connecticut
- Yale University - New Haven
District of Columbia
- George Washington University - Washington D.C.
Florida
- University of Miami - Miami
Georgia
- Emory University - Atlanta
Illinois
- Northwestern Lurie Children's Hospital of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68,000 participants |
| Start Date | 1993-04-01 |
| Est. Completion | 2030-03-31 |
What NCT00009633 shows while recruiting
NCT00009633 is an observational study that tracks outcomes without assigning an intervention. Its 68,000 participants enrollment target places it among the larger protocols in the corpus, above the 5,637-participant average among 16 other Infant, Premature trials with a reported enrollment target (1106% higher).
The record links to 4 conditions, with Infant, Premature appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.
NCT00009633 names 20 study sites across 16 states, led by California, Massachusetts, Alabama.
Frequently Asked Questions
What is clinical trial NCT00009633 about?
NCT00009633 is a clinical study titled "Follow-up Visit of High Risk Infants". The NICHD Neonatal Research Network's Follow-Up study is a multi-center cohort in which surviving extremely low birth-weight infants born in participating network centers receive neurodevelopmental, neurosensory and functional assessments at 22-26 months corrected age (Infants born prior to July 1, ...
What is the current status of trial NCT00009633?
This trial is currently recruiting. The enrollment target is 68,000 participants. The study started on 1993-04-01. Estimated completion is 2030-03-31.
What conditions does trial NCT00009633 study?
This clinical trial studies the following conditions: Infant, Premature, Infant, Newborn, Infant, Small for Gestational Age, Infant, Low Birth Weight.
What interventions are being tested in trial NCT00009633?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT00009633?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00009633 being conducted?
This trial has 20 study locations across Alabama, California, Connecticut, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infant, Premature
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00009633's enrollment target sits among peer trials
68,000 2nd of 16 the highest of 16 other Infant, Premature trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infant, Premature trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Generic Database of Very Low Birth Weight Infants
RECRUITING
-
Management of the PDA Trial
ACTIVE NOT RECRUITING · Phase 3
-
Serial Assessment of Body Fat Accrual in Very Preterm Infants
ACTIVE NOT RECRUITING · NA
-
Cerebral Function Monitoring in Premature Infants
COMPLETED
-
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
COMPLETED · Phase 2
-
Physiologic Definition of Bronchopulmonary Dysplasia
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06903897 · 68,000 participants · NA
Social Needs Screening and Chronic Diseases Study (WE CARE)
- NCT04473833 · 65,000 participants · NA
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
- NCT05128006 · 63,200 participants
Direct-to-patient Teledermatology and Computer-assisted Diagnosis
- NCT06003192 · 63,000 participants · NA
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI